HURA: Wutah dodolan triwulanan tuhurabio.com

Logo grafis TuHURA (HURA)

TuHURA Biosciences, Inc. (HURA) develops innovative anti-cancer vaccines leveraging a robust intellectual property portfolio. The high-tech "IFN-g" platform effectively combats tumor resistance, establishing a closed patent perimeter. The company is currently in the active R&D stage. The quarterly revenue growth rate helps diagnose hidden risks, with 0.00 serving as the current value of this metric.

HURA Tambahing pendapatan triwulanan TuHURA (04.07.2022 - 20.11.2026)

Rincian analitis perusahaan TuHURA (HURA)

- rega saham lan target rega konsensus:
- rincian dhuwit lan gerakan dhuwit:
Pambiji fundamental perusahaan:TuHURA Biosciences, Inc. (HURA)
Barang unggulan TuHURA Biosciences Inc.

This indicator measures quarterly revenue growth rates, reflecting the speed of business scaling by discounting market expectations. Quarterly revenue dynamics allow for a real-time assessment of the efficiency of TuHURA Biosciences, Inc. (HURA) international cell component logistics. Steady growth in this metric confirms the resilience of the laboratory hub system and high supply margins. Such a trend serves as a signal of the asset's fundamental reliability for the long-term investor.

Pesaing TuHURA Biosciences, Inc.

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|TARA - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Tingkat wutah pendapatan sajrone kuartal|TScan - Wutah pendapatan triwulanan|Champions Oncology, Inc. (CSBR) - Wutah dodolan triwulanan|XBIT (XBiotech Inc.) - Wutah dodolan triwulanan|CEL-SCI Corporation (CVM) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal OS Therapies|RADX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal artivabio.com (ARTV)|Tingkat wutah dodolan sajrone kuartal Adlai Nortye|Wutah pendapatan triwulanan VERU (Veru Corporation)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)